Main variables;Fields of operation;Total
Companies that perform R+D in Biotechnology;Total 2020;1.430
Companies that perform R+D in Biotechnology;Companies;1.233
Companies that perform R+D in Biotechnology;P.A.;118
Companies that perform R+D in Biotechnology;Higher Education;67
Companies that perform R+D in Biotechnology;PNPI;12
%Companies according to biotechnology used: Genetic code;Total 2020;39,1
%Companies according to biotechnology used: Genetic code;Companies;31,7
%Companies according to biotechnology used: Genetic code;P.A.;89
%Companies according to biotechnology used: Genetic code;Higher Education;86,6
%Companies according to biotechnology used: Genetic code;PNPI;41,7
%Companies according to biotechnology used: Functional Companies;Total 2020;45,2
%Companies according to biotechnology used: Functional Companies;Companies;38,5
%Companies according to biotechnology used: Functional Companies;P.A.;88,1
%Companies according to biotechnology used: Functional Companies;Higher Education;91
%Companies according to biotechnology used: Functional Companies;PNPI;58,3
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Total 2020;30,1
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Companies;22,8
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;P.A.;73,7
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Higher Education;80,6
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;PNPI;75
%Companies according to biotechnology used: Bioprocesses;Total 2020;55,7
%Companies according to biotechnology used: Bioprocesses;Companies;53,4
%Companies according to biotechnology used: Bioprocesses;P.A.;57,6
%Companies according to biotechnology used: Bioprocesses;Higher Education;94
%Companies according to biotechnology used: Bioprocesses;PNPI;58,3
%Companies according to biotechnology used: Sub-cellular organisms;Total 2020;15,8
%Companies according to biotechnology used: Sub-cellular organisms;Companies;8,6
%Companies according to biotechnology used: Sub-cellular organisms;P.A.;55,9
%Companies according to biotechnology used: Sub-cellular organisms;Higher Education;74,6
%Companies according to biotechnology used: Sub-cellular organisms;PNPI;33,3
%Companies according to biotechnology used: Bio-computing;Total 2020;29,2
%Companies according to biotechnology used: Bio-computing;Companies;22,3
%Companies according to biotechnology used: Bio-computing;P.A.;71,2
%Companies according to biotechnology used: Bio-computing;Higher Education;85,1
%Companies according to biotechnology used: Bio-computing;PNPI;16,7
%Companies according to biotechnology used: Nanobiotechnology;Total 2020;16,6
%Companies according to biotechnology used: Nanobiotechnology;Companies;10,6
%Companies according to biotechnology used: Nanobiotechnology;P.A.;50
%Companies according to biotechnology used: Nanobiotechnology;Higher Education;68,7
%Companies according to biotechnology used: Nanobiotechnology;PNPI;8,3
%Companies according to biotechnology used: Other;Total 2020;12,7
%Companies according to biotechnology used: Other;Companies;14,2
%Companies according to biotechnology used: Other;P.A.;1,7
%Companies according to biotechnology used: Other;Higher Education;7,5
%Companies according to biotechnology used: Other;PNPI;0
Companies in which biotechnology activities are:  Main and/or exclusive;Total 2020;653
Companies in which biotechnology activities are:  Main and/or exclusive;Companies;615
Companies in which biotechnology activities are:  Main and/or exclusive;P.A.;29
Companies in which biotechnology activities are:  Main and/or exclusive;Higher Education;2
Companies in which biotechnology activities are:  Main and/or exclusive;PNPI;7
Companies in which biotechnology activities are: A secondary line of business;Total 2020;262
Companies in which biotechnology activities are: A secondary line of business;Companies;178
Companies in which biotechnology activities are: A secondary line of business;P.A.;35
Companies in which biotechnology activities are: A secondary line of business;Higher Education;48
Companies in which biotechnology activities are: A secondary line of business;PNPI;1
Companies in which biotechnology activities are: A tool necessary for production;Total 2020;515
Companies in which biotechnology activities are: A tool necessary for production;Companies;440
Companies in which biotechnology activities are: A tool necessary for production;P.A.;54
Companies in which biotechnology activities are: A tool necessary for production;Higher Education;17
Companies in which biotechnology activities are: A tool necessary for production;PNPI;4
%Companies by field(s) of ultimate application of biotechnology use: Human health;Total 2020;51
%Companies by field(s) of ultimate application of biotechnology use: Human health;Companies;46
%Companies by field(s) of ultimate application of biotechnology use: Human health;P.A.;77
%Companies by field(s) of ultimate application of biotechnology use: Human health;Higher Education;91
%Companies by field(s) of ultimate application of biotechnology use: Human health;PNPI;67
%Companies by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Total 2020;19
%Companies by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Companies;16
%Companies by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;P.A.;19
%Companies by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Higher Education;70
%Companies by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;PNPI;25
%Companies by field(s) of ultimate application of biotechnology use: Food products;Total 2020;33
%Companies by field(s) of ultimate application of biotechnology use: Food products;Companies;32
%Companies by field(s) of ultimate application of biotechnology use: Food products;P.A.;23
%Companies by field(s) of ultimate application of biotechnology use: Food products;Higher Education;79
%Companies by field(s) of ultimate application of biotechnology use: Food products;PNPI;0
%Companies by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Total 2020;27
%Companies by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Companies;25
%Companies by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;P.A.;23
%Companies by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Higher Education;73
%Companies by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;PNPI;33
%Companies by field(s) of ultimate application of biotechnology use: Environment;Total 2020;19
%Companies by field(s) of ultimate application of biotechnology use: Environment;Companies;16
%Companies by field(s) of ultimate application of biotechnology use: Environment;P.A.;23
%Companies by field(s) of ultimate application of biotechnology use: Environment;Higher Education;76
%Companies by field(s) of ultimate application of biotechnology use: Environment;PNPI;8
%Companies by field(s) of ultimate application of biotechnology use: Industry;Total 2020;16
%Companies by field(s) of ultimate application of biotechnology use: Industry;Companies;13
%Companies by field(s) of ultimate application of biotechnology use: Industry;P.A.;14
%Companies by field(s) of ultimate application of biotechnology use: Industry;Higher Education;70
%Companies by field(s) of ultimate application of biotechnology use: Industry;PNPI;8
Personnel in R&D in biotechnology (no. of persons);Total 2020;43.568
Personnel in R&D in biotechnology (no. of persons);Companies;13.444
Personnel in R&D in biotechnology (no. of persons);P.A.;14.558
Personnel in R&D in biotechnology (no. of persons);Higher Education;15.422
Personnel in R&D in biotechnology (no. of persons);PNPI;144
Personnel in R&D in biotechnology (no. of persons): Researchers;Total 2020;28.824
Personnel in R&D in biotechnology (no. of persons): Researchers;Companies;7.378
Personnel in R&D in biotechnology (no. of persons): Researchers;P.A.;8.979
Personnel in R&D in biotechnology (no. of persons): Researchers;Higher Education;12.379
Personnel in R&D in biotechnology (no. of persons): Researchers;PNPI;88
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Total 2020;14.744
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Companies;6.066
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;P.A.;5.579
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Higher Education;3.043
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;PNPI;56
Personnel in R&D in biotechnology (no. of persons): women;Total 2020;24.402
Personnel in R&D in biotechnology (no. of persons): women;Companies;7.501
Personnel in R&D in biotechnology (no. of persons): women;P.A.;9.115
Personnel in R&D in biotechnology (no. of persons): women;Higher Education;7.689
Personnel in R&D in biotechnology (no. of persons): women;PNPI;97
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Total 2020;15.288
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Companies;4.052
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;P.A.;5.262
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Higher Education;5.916
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;PNPI;58
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Total 2020;9.115
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Companies;3.450
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;P.A.;3.853
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Higher Education;1.773
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;PNPI;39
Personnel in R&D in biotechnology (FTE);Total 2020;30.003,8
Personnel in R&D in biotechnology (FTE);Companies;9.401,9
Personnel in R&D in biotechnology (FTE);P.A.;10.846,1
Personnel in R&D in biotechnology (FTE);Higher Education;9.663,9
Personnel in R&D in biotechnology (FTE);PNPI;91,9
Personnel in R&D in biotechnology (FTE): Researchers;Total 2020;19.421,7
Personnel in R&D in biotechnology (FTE): Researchers;Companies;5.398,3
Personnel in R&D in biotechnology (FTE): Researchers;P.A.;6.270,9
Personnel in R&D in biotechnology (FTE): Researchers;Higher Education;7.692,1
Personnel in R&D in biotechnology (FTE): Researchers;PNPI;60,4
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Total 2020;10.582,1
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Companies;4.003,6
Personnel in R&D in biotechnology (FTE): Technicians and assistants;P.A.;4.575,2
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Higher Education;1.971,8
Personnel in R&D in biotechnology (FTE): Technicians and assistants;PNPI;31,5
Personnel in R&D in biotechnology (FTE): women;Total 2020;17.268,4
Personnel in R&D in biotechnology (FTE): women;Companies;5.426,2
Personnel in R&D in biotechnology (FTE): women;P.A.;6.853,1
Personnel in R&D in biotechnology (FTE): women;Higher Education;4.923,3
Personnel in R&D in biotechnology (FTE): women;PNPI;65,8
Personnel in R&D in biotechnology (FTE): (women) Researchers;Total 2020;10.512,7
Personnel in R&D in biotechnology (FTE): (women) Researchers;Companies;3.016,4
Personnel in R&D in biotechnology (FTE): (women) Researchers;P.A.;3.680,8
Personnel in R&D in biotechnology (FTE): (women) Researchers;Higher Education;3.774,1
Personnel in R&D in biotechnology (FTE): (women) Researchers;PNPI;41,4
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Total 2020;6.755,7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Companies;2.409,8
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;P.A.;3.172,3
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Higher Education;1.149,2
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;PNPI;24,4
Internal expenditure on R&D (thousands of euros);Total 2020;2.059.394
Internal expenditure on R&D (thousands of euros);Companies;897.333
Internal expenditure on R&D (thousands of euros);P.A.;678.685
Internal expenditure on R&D (thousands of euros);Higher Education;477.628
Internal expenditure on R&D (thousands of euros);PNPI;5.748
1) By nature of the expense: Current expenses;Total 2020;1.896.836
1) By nature of the expense: Current expenses;Companies;817.409
1) By nature of the expense: Current expenses;P.A.;632.188
1) By nature of the expense: Current expenses;Higher Education;441.712
1) By nature of the expense: Current expenses;PNPI;5.526
1.1) Remuneration to researchers;Total 2020;815.653
1.1) Remuneration to researchers;Companies;295.705
1.1) Remuneration to researchers;P.A.;238.938
1.1) Remuneration to researchers;Higher Education;279.152
1.1) Remuneration to researchers;PNPI;1.859
1.2) Remuneration to technicians and assistants;Total 2020;346.532
1.2) Remuneration to technicians and assistants;Companies;156.853
1.2) Remuneration to technicians and assistants;P.A.;127.778
1.2) Remuneration to technicians and assistants;Higher Education;61.050
1.2) Remuneration to technicians and assistants;PNPI;851
1.3) Other current expenses;Total 2020;734.651
1.3) Other current expenses;Companies;364.852
1.3) Other current expenses;P.A.;265.472
1.3) Other current expenses;Higher Education;101.510
1.3) Other current expenses;PNPI;2.817
2) By nature of the expense: Capital expenses;Total 2020;162.558
2) By nature of the expense: Capital expenses;Companies;79.924
2) By nature of the expense: Capital expenses;P.A.;46.497
2) By nature of the expense: Capital expenses;Higher Education;35.916
2) By nature of the expense: Capital expenses;PNPI;221
2.1) Land and buildings;Total 2020;21.618
2.1) Land and buildings;Companies;10.272
2.1) Land and buildings;P.A.;4.863
2.1) Land and buildings;Higher Education;6.483
2.1) Land and buildings;PNPI;0
2.2) Equipment and instruments;Total 2020;125.071
2.2) Equipment and instruments;Companies;56.609
2.2) Equipment and instruments;P.A.;40.467
2.2) Equipment and instruments;Higher Education;27.780
2.2) Equipment and instruments;PNPI;216
2.3) Acquisition of specific R+D software;Total 2020;7.349
2.3) Acquisition of specific R+D software;Companies;4.839
2.3) Acquisition of specific R+D software;P.A.;969
2.3) Acquisition of specific R+D software;Higher Education;1.541
2.3) Acquisition of specific R+D software;PNPI;1
2.4) Otros productos de propiedad intelectual específicos para I+D;Total 2020;8.519
2.4) Otros productos de propiedad intelectual específicos para I+D;Companies;8.203
2.4) Otros productos de propiedad intelectual específicos para I+D;P.A.;199
2.4) Otros productos de propiedad intelectual específicos para I+D;Higher Education;112
2.4) Otros productos de propiedad intelectual específicos para I+D;PNPI;5
1.1) By origin of the funds: Own funds;Total 2020;772.786
1.1) By origin of the funds: Own funds;Companies;613.097
1.1) By origin of the funds: Own funds;P.A.;68.653
1.1) By origin of the funds: Own funds;Higher Education;88.724
1.1) By origin of the funds: Own funds;PNPI;2.311
1.2) By origin of the funds: From companies;Total 2020;222.014
1.2) By origin of the funds: From companies;Companies;86.085
1.2) By origin of the funds: From companies;P.A.;110.014
1.2) By origin of the funds: From companies;Higher Education;25.119
1.2) By origin of the funds: From companies;PNPI;796
1.3) By origin of the funds: Public Administration funds;Total 2020;824.067
1.3) By origin of the funds: Public Administration funds;Companies;92.140
1.3) By origin of the funds: Public Administration funds;P.A.;416.365
1.3) By origin of the funds: Public Administration funds;Higher Education;314.573
1.3) By origin of the funds: Public Administration funds;PNPI;989
1.4) By origin of the funds: From Universities;Total 2020;6.337
1.4) By origin of the funds: From Universities;Companies;853
1.4) By origin of the funds: From Universities;P.A.;1.238
1.4) By origin of the funds: From Universities;Higher Education;4.246
1.4) By origin of the funds: From Universities;PNPI;0
1.5) By origin of the funds: From non profit private institutions;Total 2020;29.754
1.5) By origin of the funds: From non profit private institutions;Companies;4.682
1.5) By origin of the funds: From non profit private institutions;P.A.;15.618
1.5) By origin of the funds: From non profit private institutions;Higher Education;8.422
1.5) By origin of the funds: From non profit private institutions;PNPI;1.032
1.6) By origin of the funds: Foreign funds;Total 2020;204.436
1.6) By origin of the funds: Foreign funds;Companies;100.476
1.6) By origin of the funds: Foreign funds;P.A.;66.798
1.6) By origin of the funds: Foreign funds;Higher Education;36.544
1.6) By origin of the funds: Foreign funds;PNPI;619
Purchase of services R & D in Biotechnology to (thousands of euros);Total 2020;114.577
Purchase of services R & D in Biotechnology to (thousands of euros);Companies;85.011
Purchase of services R & D in Biotechnology to (thousands of euros);P.A.;21.442
Purchase of services R & D in Biotechnology to (thousands of euros);Higher Education;7.429
Purchase of services R & D in Biotechnology to (thousands of euros);PNPI;695
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Total 2020;81.403
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Companies;54.243
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;P.A.;19.374
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Higher Education;7.134
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;PNPI;652
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Total 2020;33.174
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Companies;30.768
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;P.A.;2.068
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Higher Education;294
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;PNPI;43
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Total 2020;42,2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Companies;39,2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;P.A.;61
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Higher Education;58,2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;PNPI;75
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Total 2020;10,9
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Companies;11,7
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;P.A.;3,4
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Higher Education;10,4
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;PNPI;8,3
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Total 2020;16,2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Companies;12,5
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;P.A.;41,5
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Higher Education;38,8
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;PNPI;25
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Total 2020;13,6
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Companies;10,9
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;P.A.;29,7
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Higher Education;34,3
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;PNPI;16,7
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Total 2020;17,1
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Companies;14,3
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;P.A.;31,4
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Higher Education;41,8
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;PNPI;25
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Total 2020;19
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Companies;17
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;P.A.;29
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Higher Education;40
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;PNPI;25
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Total 2020;14,5
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Companies;15
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;P.A.;9,3
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Higher Education;10,4
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;PNPI;33,3
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Total 2020;36
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Companies;36
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;P.A.;37
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Higher Education;34
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;PNPI;58
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;Total 2020;48,6
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;Companies;46,7
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;P.A.;60,2
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;Higher Education;59,7
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;PNPI;66,7
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Total 2020;19
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Companies;19
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;P.A.;21,2
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Higher Education;13,4
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;PNPI;25
%Companies that have requested biotechnology patents in Biotechnology;Total 2020;22,9
%Companies that have requested biotechnology patents in Biotechnology;Companies;17,3
%Companies that have requested biotechnology patents in Biotechnology;P.A.;53,4
%Companies that have requested biotechnology patents in Biotechnology;Higher Education;73,1
%Companies that have requested biotechnology patents in Biotechnology;PNPI;8,3
Number of patents requested;Total 2020;1.991
Number of patents requested;Companies;681
Number of patents requested;P.A.;698
Number of patents requested;Higher Education;611
Number of patents requested;PNPI;1